OliX Pharmaceuticals, Inc (KOSDAQ:226950)

OliX Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	823,648	355,531	233,568	278,859	561,830	681,166
Market Cap Growth	167.63%	52.22%	-16.24%	-50.37%	-17.52%	146.02%
Enterprise Value	841,309	392,701	247,386	238,494	524,125	657,538
Last Close Price	41600.00	19260.00	14580.00	20350.00	41000.00	50300.00
PS Ratio	139.95	62.63	13.69	29.92	152.91	275.30
PB Ratio	31.72	19.25	4.64	4.21	28.95	15.02
P/TBV Ratio	34.75	22.02	4.92	4.48	34.29	15.93
EV/Sales Ratio	142.95	69.17	14.50	25.59	142.64	265.75
Debt / Equity Ratio	1.10	2.12	0.78	0.67	1.92	0.32
Asset Turnover	0.07	0.07	0.14	0.09	0.04	0.04
Inventory Turnover	0.40	0.49	0.28	0.40	0.51	0.18
Quick Ratio	0.60	0.44	4.71	1.59	1.24	15.21
Current Ratio	0.73	0.52	4.90	1.65	1.29	15.38
Return on Equity (ROE)	-144.63%	-118.18%	-32.78%	-65.68%	-90.11%	-44.48%
Return on Assets (ROA)	-21.27%	-22.20%	-9.65%	-12.75%	-18.33%	-16.40%
Return on Capital (ROIC)	-26.27%	-26.23%	-11.37%	-16.76%	-25.98%	-19.92%
Earnings Yield	-5.53%	-11.44%	-8.18%	-6.99%	-5.29%	-2.85%
FCF Yield	-4.18%	-11.68%	-12.84%	-11.80%	-3.62%	-0.67%
Buyback Yield / Dilution	-15.25%	-16.73%	-5.30%	-0.13%	-4.06%	-1.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.